The National Residential Medication Chart User Guide for Pharmacists is intended for pharmacists who provide services to residential care facilities (RCFs) and who are authorised to supply and claim for medicines under the Pharmaceutical Benefits Scheme (PBS) or Repatriation Pharmaceutical Benefits Scheme (RPBS).
The National Residential Medication Chart User Guide for Prescribers is intended for prescribers who provide services to residential care facilities and who are authorised to prescribe medicines under the Pharmaceutical Benefits Scheme (PBS) or Repatriation Pharmaceutical Benefits Scheme (RPBS).
The Acute Anaphylaxis Clinical Care Standard was endorsed by the following organisations in 2021:
Patients who have experienced anaphylaxis are observed in a setting with facilities to manage deterioration or a biphasic reaction.
To avoid harm resulting from delayed administration of adrenaline to patients with anaphylaxis who have their own adrenaline injector and could self-medicate safely during a healthcare encounter or admission.
To reduce adverse outcomes during or after anaphylaxis due to low blood pressure. Fatality can occur within minutes if a patient stands or sits up suddenly while they have inadequate perfusion.
To ensure immediate treatment with intramuscular adrenaline as soon as anaphylaxis is recognised or suspected and prevent progression to life-threatening symptoms.